September 26, 2026

Global Deep Dives

Amazon’s $220 Billion AI Capex: AWS Growth Is Strong Enough—For Now

AWS growth accelerated to 37% while Amazon lifted 2026 capex to $220 billion. I examine backlog, free cash flow and whether the spending still creates value.

Mehr lesen

Tesla Cybercab Is Finally Moving. The Stock Still Needs Robotaxi Economics.

Tesla is preparing its Cybercab rollout while capex surges and auto margins stay weak. I examine what robotaxi economics must deliver to justify the valuation.

Mehr lesen

Nvidia’s $105 Billion OpenAI Guarantee: When Chip Demand Starts Financing Itself

Nvidia may guarantee up to $105 billion for an OpenAI data-center lease. I examine what this says about AI demand, circular financing and Nvidia’s valuation.

Mehr lesen

Why Rising Bond Yields Hit Tech Stocks So Hard: A Practical Duration Guide

Long-term bond yields are rising and tech stocks are selling off. Here is the valuation math behind duration, discount rates and why growth shares react so violently.

Mehr lesen

Amazon: AWS Is Accelerating. The AI Capex Bill Is Accelerating Faster.

AWS growth accelerated sharply in Q2, but Amazon’s AI infrastructure spending pushed free cash flow negative. I examine whether the investment cycle is creating enough value.

Mehr lesen

Nvidia Stock After Q2 FY2027: $96 Billion of Revenue—and the Working-Capital Shadow

Nvidia’s Q2 FY2027 revenue reached $96.2 billion. A close look at margins, cash conversion, AI financing, China risk and the $5.09 trillion valuation.

Mehr lesen

Marvell’s Google AI Chip Deal Is Huge. The Dilution Is the Price of Admission.

Google’s custom-AI-chip agreement could generate enormous revenue for Marvell, but the warrant can also dilute shareholders. I examine what the deal is really worth.

Mehr lesen

Tesla’s Cybercab Launch Is the Test the Valuation Can No Longer Avoid

Tesla is preparing a broader Cybercab rollout while auto margins remain thin and AI spending rises. I examine what robotaxi economics must deliver to justify the valuation.

Mehr lesen

Moderna’s Cancer Vaccine Breakthrough Is Real. The Valuation Is Now the Harder Question.

Moderna’s personalized cancer vaccine just delivered the kind of Phase 3 result the mRNA platform needed. The science looks far more credible today. The stock price, however, now asks a.

Mehr lesen

Cisco: AI Has Revived One of Technology’s Oldest Giants

THE CAPITAL · STOCK ANALYSIS · AUGUST 13, 2026 Cisco just reported $17.3 billion of quarterly revenue, $9.3 billion of full-year AI infrastructure orders and a fiscal 2027 outlook far.

Mehr lesen